Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Xenon Pharmaceuticals Inc XENE

Healthcare Biotechnology
Xenon Pharmaceuticals Inc. is a Canada-based neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing therapeutics to improve the lives of people living with neurological and psychiatric disorders. The Company is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. Azetukalner, the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:XENE)

Xenon Outlines Key Corporate Milestone Opportunities for 2025

GlobeNewswire 1 day ago

Xenon to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire 7 days ago

Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024

GlobeNewswire December 6, 2024

Xenon to Showcase New Long-Term Azetukalner Data at AES 2024

GlobeNewswire November 25, 2024

Xenon to Present at Upcoming Investor Conferences

GlobeNewswire November 13, 2024

Xenon Reports Q3 2024 Financial Results and Business Update

GlobeNewswire November 12, 2024

Xenon to Report Q3 2024 Financial Results on November 12, 2024

GlobeNewswire November 5, 2024

Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference

GlobeNewswire October 2, 2024

Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress

GlobeNewswire September 9, 2024
View More News ››

Opinion & Analysis (NDAQ:XENE)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:XENE)

Xenon Pharmaceuticals Inc. (XENE): A Promising Neuroscience-

http://beyondspx.com/2024/08/01/xenon-pharmaceuticals-inc-xene-a-promising-neuroscience-focused-biopharmaceutical-company/
MikeTester - August 1, 2024

4 PROMISING BIOTECH STOCKS WITH IMMENSE POTENTIAL!

$XENE $CPRX $KRYS $VBIV Read on to know more: https://www.aviseanalytics.com/4-promising-biotech-stocks-with-immense...
AviseAnalytics - December 13, 2021

Excellent company and drug

Extremely solid scientific backing and upcoming milestones which are looking VERY positive based on their previous data.  Could...
BioTechGuru3314 - June 25, 2019

new fiiling

https://www.sec.gov/Archives/edgar/data/1582313/999999999717008485/filename1.pdf
Dimibear74 - September 6, 2017

new in

I bought it yesterday
Abdelhak - March 2, 2017

RE:Anyone following this company out there?

There has been recently positive review by Bret Jensen's Seeking Alpha Instablog. http://seekingalpha.com/instablog/498952-bret...
RskEtrader - October 23, 2016
View more Bullboard ››

Tidal Care Inc.

Tidal Care Inc.

Tidal Care aims to be a high-compliance supplier of finished, formulated Psilocybin- and MDMA-based drug products to the ...
View More »